Group 1 - The company has two production bases in Europe located in Poland and Germany [1] - A new sales company in Hungary is expected to be established in the first half of 2025 [1] - The company's sales strategy in Europe includes direct exports to European customers and sales through subsidiaries established in Europe [1]

Core Viewpoint - Samsung Medical is committed to advancing its digital transformation strategy to enhance patient experience and medical quality [1] Group 1: Digital Transformation Strategy - The company is focusing on building an integrated patient service mini-program based on systems such as "case quality control system," "rehabilitation treatment system," "clinical pathway system," and "internet medical services" [1] - The aim is to promote intelligent upgrades of in-hospital diagnosis and treatment services and the informatization of grade evaluation [1] Group 2: Goals and Vision - Samsung Medical seeks to comprehensively construct a new ecosystem of smart, efficient, and safe medical services [1]

Group 1 - The core stock price of Samsung Medical (601567) closed at 24.75 yuan on January 15, 2026, with an increase of 1.02% and a turnover rate of 1.27% [1] - The trading volume was 178,300 shares, with a total transaction amount of 439 million yuan [1] - On January 15, the main funds had a net outflow of 9.54 million yuan, accounting for 2.17% of the total transaction amount [2] Group 2 - Samsung Medical provided a performance guarantee for its wholly-owned subsidiary, Brazil Nansen, with a guarantee amount of approximately 44.07 million yuan, and the guarantee period has been extended to January 30, 2027 [1][2] - The guarantee has been approved by the board of directors and shareholders, and it falls within the previously estimated guarantee limit [1] - As of the announcement date, the total external guarantees of the company amounted to 975.35 million yuan, which is 80.73% of the most recent audited net assets, with no overdue guarantees [1]

Core Viewpoint - Samsung Medical (601567) experienced a decline in stock price, closing at 24.5 yuan on January 14, 2026, with a trading volume of 306,300 hands and a total transaction amount of 760 million yuan [1] Group 1: Financial Performance - For the first three quarters of 2025, Samsung Medical reported a main revenue of 11.08 billion yuan, an increase of 6.19% year-on-year [3] - The net profit attributable to shareholders was 1.528 billion yuan, a decrease of 15.85% year-on-year [3] - The net profit after deducting non-recurring items was 1.28 billion yuan, down 26.81% year-on-year [3] - In Q3 2025, the company’s single-quarter main revenue was 3.108 billion yuan, a decline of 9.56% year-on-year [3] - The single-quarter net profit attributable to shareholders was 298 million yuan, a decrease of 55.22% year-on-year [3] - The single-quarter net profit after deducting non-recurring items was 144 million yuan, down 78.54% year-on-year [3] - The company’s debt ratio stood at 47.57%, with investment income of 179 million yuan and financial expenses of -109 million yuan [3] - The gross profit margin was reported at 28.46% [3] Group 2: Market Activity - On January 14, 2026, the net outflow of main funds was 1.4346 million yuan, accounting for 0.19% of the total transaction amount [1] - Retail investors saw a net inflow of 22.827 million yuan, representing 3.01% of the total transaction amount [1] - Over the past five days, the financing buy amounted to 82.3109 million yuan, while financing repayment was 76.1522 million yuan, resulting in a net financing increase of 6.1587 million yuan [2] - The total financing and securities balance was reported at 383 million yuan [2] Group 3: Analyst Ratings - In the last 90 days, six institutions have given buy ratings for Samsung Medical, with an average target price of 30.16 yuan [4]

宁波三星医疗电气股份有限公司 关于为子公司提供担保的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 担保对象及基本情况 | 担保 | 被担保人名称 | NANSEN | INSTRUMENTOS LTDA.（以下简称"巴西南森"） | DE | PRECISÃO | | --- | --- | --- | --- | --- | --- | | | 本次担保金额 | 3,390.24 | 万巴西雷亚尔（约 | 4,407.32 | 万人民币） | | 对象 | 实际为其提供的担保余额 | 4,407.32 | 万元（含本次担保） | | | | | 是否在前期预计额度内 | 是 □否 | □不适用：_________ | | | | | 本次担保是否有反担保 | □是 否 | □不适用：_________ | | | 累计担保情况 | 对外担保逾期的累计金额（万元） | 0 | | --- | --- | | 截至本公告日上市公司及其控股 子公司对外担保总额（万元） | 975,350.00 | ...

Group 1 - Guodian NARI (600406) is a state-owned enterprise based in Nanjing, recognized as a benchmark for scientific reform among central enterprises, with a strong research and development system and significant achievements in grid technology [1] - The company has a market share of over 75% in dispatch automation systems and over 50% in UHV converter valves, with its products addressing grid stability issues caused by renewable energy generation [1] - The demand for AI computing power and electricity is driving the construction of new power systems, and the company is expanding its overseas business, exporting products like distribution transformers to multiple countries [1] Group 2 - Suyuan Electric (002028) is a comprehensive supplier of power transmission and distribution based in Shanghai, focusing on UHV and energy storage sectors, and is the largest manufacturer of high-voltage packages and coils in China [2] - The company expects 60% of its overseas revenue in 2024 to come from transformers, with overseas orders growing over 50% and a remarkable 89% growth in the first half of 2025 [2] - The surge in demand for high-voltage transmission and distribution equipment driven by AI computing centers and new energy projects presents significant growth opportunities for the company [2] Group 3 - China XD Electric (601179) is a state-owned enterprise based in Xi'an, specializing in high and ultra-high voltage transformers and power transmission and distribution equipment, capable of producing products across a voltage range of 10kV to 1000kV [3] - The company has a significant market share in UHV projects and has seen an increase in exports to Europe, with its technology reaching international advanced levels [3] - The demand for UHV technology is increasing due to the need for long-distance power transmission, and the company is well-positioned to meet both domestic and international market needs [3] Group 4 - Baobian Electric (600550) is a core supplier of UHV DC transformers based in Baoding, with a strong position in high-end transformers and a market share of 30% in UHV products [4] - The company has unique technologies that reduce material costs and has participated in major projects, exporting to over 40 countries [4] - The urgent demand for high-reliability transformers driven by AI computing centers and new energy power stations positions the company to benefit from both domestic and international projects [4] Group 5 - Jinpan Technology (688676) is a leading global manufacturer of dry-type transformers based in Haikou, focusing on wind and solar energy applications, with 98% of its products supporting renewable energy [5] - The company has a significant order backlog of 2.85 billion yuan for 2025, reflecting a substantial year-on-year growth of 180% [5] - The increasing demand for efficient dry-type transformers from AI computing centers and the proliferation of renewable energy generation presents a strong growth opportunity for the company [5] Group 6 - Mingyang Electric (301291) is a leader in offshore wind power transformers based in Zhongshan, specializing in dry-type transformers and prefabricated substations [6] - The company has developed products that meet the extreme conditions of offshore environments and is expected to achieve significant sales in North America by 2026 [6] - The growing demand for offshore wind power and the urgent need for grid upgrades in North America provide ample order support for the company [6] Group 7 - Teruid (300001) is a pioneer in outdoor box-type power equipment based in Qingdao, recognized as a champion enterprise in manufacturing [7] - The company has a complete technology system for modular prefabricated substations and has a leading market share in the new energy sector [7] - The demand for modular products from AI computing centers and the need for grid upgrades position the company to capture significant market growth [7] Group 8 - XJ Electric (000400) is a high-tech enterprise based in Xuchang, focusing on UHV and smart grid technologies, with a comprehensive industrial chain covering all aspects of power transmission and distribution [8] - The company has participated in all domestic UHV DC transmission projects and has a strong patent portfolio [8] - The growth in AI computing and electricity demand is accelerating the construction of smart grids, providing competitive advantages for the company [8] Group 9 - Sifang Co., Ltd. (601126) is based in Beijing and has a strong advantage in smart distribution networks, providing a full range of products for self-healing control and primary and secondary integration [9] - The company has implemented its products in over 30 provinces and cities, significantly improving efficiency in power distribution [9] - The demand for reliable power supply from AI computing centers and the ongoing digital transformation of distribution networks present broad development opportunities for the company [9] Group 10 - Samsung Medical (601567) is based in Ningbo and operates in both smart power distribution and medical services, covering a wide range of products in the power equipment sector [10] - The company has established manufacturing bases in multiple locations and has a marketing presence in over 70 countries [10] - The construction of AI computing centers and new energy projects requires substantial power distribution equipment, positioning the company to benefit from global demand growth [10]

Core Viewpoint - Samsung Medical (601567) has seen a stock price increase of 6.21% this week, closing at 24.45 yuan as of January 9, 2026, compared to 23.02 yuan the previous week [1] Company Performance - The highest stock price during the week was 25.15 yuan on January 6, while the lowest was 22.88 yuan on January 5 [1] - The current total market capitalization of Samsung Medical is 34.357 billion yuan, ranking 9th out of 123 in the power equipment sector and 596th out of 5,182 in the A-share market [1] Company Announcements - Samsung Medical has completed the registration capital change, with the new registered capital amounting to 1,405,209,400 yuan [1] - On October 29, 2025, the company held its 26th meeting of the 6th Board of Directors, where it approved the change in registered capital and the revision of the Articles of Association, followed by the completion of the relevant business registration procedures [1] - The company has obtained a new business license from the Ningbo Market Supervision Administration, reflecting changes in registered capital and other registration details such as company name, type, unified social credit code, address, legal representative, establishment date, and business scope [1]

证券代码：601567 证券简称：三星医疗 公告编号：临2026-001 宁波三星医疗电气股份有限公司 法定代表人：沈国英 注册资本：1,405,209,400元 成立日期：2007年02月01日 关于完成工商变更登记的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 宁波三星医疗电气股份有限公司（以下简称"公司"）于2025年10月29日召开第六届董事会第二十六次会 议，审议通过了《关于公司变更注册资本、修订〈公司章程〉并办理工商变更登记的议案》。具体详见 公司于2025年10月30日披露于上海证券交易所网站（www.sse.com.cn）、中国证券报、上海证券报和证 券时报的《三星医疗第六届董事会第二十六次会议决议公告》（公告编号：临2025-082）、《三星医疗 关于公司变更注册资本、修订〈公司章程〉并办理工商变更登记的公告》（公告编号：临2025-083）等 相关公告。 近日，公司完成了相关工商变更登记手续，并取得了宁波市市场监督管理局换发的《营业执照》。工商 登记变更后，相关登记信息如下： 公司名称：宁波三星医疗 ...

（编辑 任世碧） 证券日报网讯 1月7日，三星医疗发布公告称，公司于2025年10月29日召开第六届董事会第二十六次会 议，审议通过了《关于公司变更注册资本、修订并办理工商变更登记的议案》。近日，公司完成了相关 工商变更登记手续，并取得了宁波市市场监督管理局换发的《营业执照》。 ...

证券代码：601567 证券简称：三星医疗 公告编号：临 2026-001 宁波三星医疗电气股份有限公司（以下简称"公司"）于 2025 年 10 月 29 日召开第六届董事会第二十六次会议，审议通过了《关于公司变更注册资本、修 订<公司章程>并办理工商变更登记的议案》。具体详见公司于 2025 年 10 月 30 日披露于上海证券交易所网站（www.sse.com.cn）、中国证券报、上海证券报和 证券时报的《三星医疗第六届董事会第二十六次会议决议公告》（公告编号：临 2025-082）、《三星医疗关于公司变更注册资本、修订<公司章程>并办理工商变更 登记的公告》（公告编号：临 2025-083）等相关公告。 近日，公司完成了相关工商变更登记手续，并取得了宁波市市场监督管理局 换发的《营业执照》。工商登记变更后，相关登记信息如下： 宁波三星医疗电气股份有限公司 关于完成工商变更登记的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 特此公告。 宁波三星医疗电气股份有限公司 董事会 二〇二六年一月八日 住所：浙江省宁波市鄞 ...